Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy

Netherlands Journal of Medicine

Volumn 63, Issue 1, 2005, Pages 20-23

  Bierdrager, E ^a,b   Lampmann, L E H ^a   Lohle, P N M ^a   Schoemaker, C M ^a   Schijen, J H E M ^a   Palmen, F M L H G ^a   van der Heul, C ^a  

^a CPRLab   (Netherlands)

^b Flevoziekenhuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IOHEXOL; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOVASCULAR SURGERY; FEASIBILITY STUDY; FEMALE; GENERAL ANESTHESIA; HUMAN; LOCAL ANESTHESIA; MALE; NURSING STAFF; PATIENT REFERRAL; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATION; RADIOLOGY DEPARTMENT; STENT; SUPERIOR CAVA VEIN SYNDROME; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; VASCULAR TUMOR;

AGED; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; NEOPLASMS; PALLIATIVE CARE; PHLEBOGRAPHY; STENTS; SUPERIOR VENA CAVA SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; VENA CAVA, SUPERIOR;

EID: 13444263970     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Baker GL, Barnes JH. Superior vena cava syndrome: Aetiology, diagnosis, and treatment. Am J Crit Care 1992;1:54-64.
2. Parish JM, Marschke RF, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc 1981;56:407-13.
3. Perez CA, Presant CA, van Amburg AL III. Management of superior vena cava syndrome. Semin Oncol 1978;5:123-35.
4. Wurschmidt F, Bunemann H, Heilmann HP. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases. Int J Radiat Oncol Biol Phys 1995;33:77-82.
5. Urban T, Lebeau B, Chastang C, et al. Superior vena cava syndrome in small cell lung cancer. Arch Intern Med 1993;153:384-7.
6. Stanford W, Jolles H, Ell S, Chiu LC. Superior vena cava obstruction: venographic classification. AJR Am J Roentgenol 1987;148:259-62.
7. Rowell NP, Gleeson FV. Steroids, radiotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systemic review. Clin Oncol 2002;14(5):338-51.
8. Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997;8(5):781-8.
9. Schindler N, Vogelzang RL. Superior vena cava syndrome. Experience with endovascular stents and surgical therapy. Surg Clin North Am 1999;79(3):683-94.
10. Urruticoechea A, Mesia R, Dominguez J, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. Lung Cancer 2004;43:209-14.